Genetic contributions to labor Pain and progress

Clinics in Perinatology

Volumn 40, Issue 3, 2013, Pages 575-587

  Landau, Ruth ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

ADRB2; Genetics; Labor pain; OPRM1; Polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOL METHYLTRANSFERASE; FENTANYL; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; OXYTOCIN RECEPTOR; SUFENTANIL;

BETA2 ADRENERGIC RECEPTOR GENE; CATECHOL O METHYLTRANSFERASE GENE; DISEASE COURSE; DOSE RESPONSE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LABOR PAIN; LOW DRUG DOSE; MOLECULAR DYNAMICS; MU OPIOID RECEPTOR GENE; NOCICEPTION; OXYTOCIN RECEPTOR GENE; PAIN ASSESSMENT; PHENOTYPE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ADRB2; GENETICS; LABOR PAIN; OPRM1; POLYMORPHISM;

ANALGESIA, OBSTETRICAL; ANALGESICS, OPIOID; CATECHOL O-METHYLTRANSFERASE; FEMALE; FENTANYL; HUMANS; LABOR PAIN; LABOR, OBSTETRIC; OBSTETRIC LABOR COMPLICATIONS; OBSTETRIC LABOR, PREMATURE; PAIN PERCEPTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREMATURE BIRTH; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, OPIOID, MU; RECEPTORS, OXYTOCIN;

EID: 84882840987     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2013.05.014     Document Type: Review

References (75)

1. Mogil J.S. Are we getting anywhere in human pain genetics?. Pain 2009, 146:231-232.
2. Candiotti K. Anesthesia and pharmacogenomics: not ready for prime time. Anesth Analg 2009, 109:1377-1378.
3. Donahue B.S., Balser J.R. Perioperative genomics. Venturing into uncharted seas. Anesthesiology 2003, 99:7-8.
4. Schwinn D.A., Booth J.V. Genetics infuses new life into human physiology: implications of the human genome project for anesthesiology and perioperative medicine. Anesthesiology 2002, 96:261-263.
5. Available at:. Accessed March 27, 2013. http://www.pharmgkb.org.
6. Relling M.V., Klein T.E. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther 2011, 89:464-467.
7. Crews K.R., Gaedigk A., Dunnenberger H.M., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 2012, 91:321-326.
8. Melzack R. The myth of painless childbirth (the John J. Bonica lecture). Pain 1984, 19:321-337.
9. Available at:. Accessed March 27, 2013. http://www.iasp-pain.org.
10. Carvalho B., Cohen S.E. Measuring the labor pain experience: delivery still far off. Int J Obstet Anesth 2013, 22:6-9.
11. Kannan S., Jamison R.N., Datta S. Maternal satisfaction and pain control in women electing natural childbirth. Reg Anesth Pain Med 2001, 26:468-472.
12. Conell-Price J., Evans J.B., Hong D., et al. The development and validation of a dynamic model to account for the progress of labor in the assessment of pain. Anesth Analg 2008, 106:1509-1515.
13. Landau R., Cahana A., Smiley R.M., et al. Genetic variability of mu-opioid receptor in an obstetric population. Anesthesiology 2004, 100:1030-1033.
14. Tan E.C., Tan C.H., Karupathivan U., et al. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 2003, 14:569-572.
15. Crowley J.J., Oslin D.W., Patkar A.A., et al. Agenetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 2003, 13:169-173.
16. Kroslak T., Laforge K.S., Gianotti R.J., et al. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. JNeurochem 2007, 103:77-87.
17. Bond C., LaForge K.S., Tian M., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998, 95:9608-9613.
18. Zhang Y., Wang D., Johnson A.D., et al. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. JBiol Chem 2005, 280:32618-32624.
19. Beyer A., Koch T., Schroder H., et al. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. JNeurochem 2004, 89:553-560.
20. Oertel B.G., Kettner M., Scholich K., et al. Acommon human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. JBiol Chem 2009, 284:6530-6535.
21. Mahmoud S., Thorsell A., Sommer W.H., et al. Pharmacological consequence of the A118G mu opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca(2) channels in humanized mouse sensory neurons. Anesthesiology 2011, 115:1054-1062.
22. Fillingim R.B., Kaplan L., Staud R., et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. JPain 2005, 6:159-167.
23. Huang C.J., Liu H.F., Su N.Y., et al. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia 2008, 63:1288-1295.
24. Vossen H., Kenis G., Rutten B., et al. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One 2010, 5:e13641.
25. Zwisler S.T., Enggaard T.P., Noehr-Jensen L., et al. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes. Fundam Clin Pharmacol 2010, 24:517-524.
26. Doehring A., Kusener N., Fluhr K., et al. Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures. PLoS One 2011, 6:e17724.
27. Hastie B.A., Riley J.L., Kaplan L., et al. Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity. Pain 2012, 153:1610-1619.
28. Nielsen D.A., Hamon S., Yuferov V., et al. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet 2010, 127:639-649.
29. Pettersson F.D., Gronbladh A., Nyberg F., et al. The A118G single-nucleotide polymorphism of human mu-opioid receptor gene and use of labor analgesia. Reprod Sci 2012, 19:962-967.
30. Dabo F., Gronbladh A., Nyberg F., et al. Different SNP combinations in the GCH1 gene and use of labor analgesia. Mol Pain 2010, 6:41.
31. Landau R., Kern C., Columb M.O., et al. Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain 2008, 139:5-14.
32. Wong C.A., McCarthy R.J., Blouin J., et al. Observational study of the effect of mu- opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post- cesarean delivery analgesia. Int J Obstet Anesth 2010, 19:246-253.
33. Camorcia M., Capogna G., Stirparo S., et al. Effect of mu-opioid receptor A118G polymorphism on the ED50 of epidural sufentanil for labor analgesia. Int J Obstet Anesth 2012, 21(1):40-44.
34. Landau R., Liu S.K., Blouin J.L., et al. The effect of OPRM1 and COMT genotypes on the analgesic response to intravenous fentanyl labor analgesia. Anesth Analg 2013, 116:386-391.
35. Walter C., Lotsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 2009, 146:270-275.
36. Fukuda K., Hayashida M., Ide S., et al. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain 2009, 147:194-201.
37. Wu W.D., Wang Y., Fang Y.M., et al. Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. Mol Diagn Ther 2009, 13:331-337.
38. Zhang W., Chang Y.Z., Kan Q.C., et al. Association of human mu-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia 2009, 65:130-135.
39. Sia A.T., Lim Y., Lim E.C., et al. A118G single nucleotide polymorphism of human mu-morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008, 109:520-526.
40. Chou W.Y., Wang C.H., Liu P.H., et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006, 105:334-337.
41. Coulbault L., Beaussier M., Verstuyft C., et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clin Pharmacol Ther 2006, 79:316-324.
42. Klepstad P., Fladvad T., Skorpen F., et al. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain 2011, 152:1139-1145.
43. Klepstad P., Rakvag T.T., Kaasa S., et al. The 118 A> G polymorphism in the human mu- opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 2004, 48:1232-1239.
44. Reyes-Gibby C.C., Shete S., Rakvag T., et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 2007, 130:25-30.
45. Diatchenko L., Nackley A.G., Slade G.D., et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006, 125:216-224.
46. Belfer I., Segall S. COMT genetic variants and pain. Drugs Today (Barc) 2011, 47:457-467.
47. Tammimaki A., Mannisto P.T. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis. Pharmacogenet Genomics 2012, 22:673-691.
48. Kolesnikov Y., Gabovits B., Levin A., et al. Combined catechol-O- methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. Anesth Analg 2011, 112:448-453.
49. Lee P.J., Delaney P., Keogh J., et al. Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity. Clin J Pain 2011, 27:93-101.
50. Hickey O.T., Nugent N.F., Burke S.M., et al. Persistent pain after mastectomy with reconstruction. JClin Anesth 2011, 23:482-488.
51. Jensen K.B., Lonsdorf T.B., Schalling M., et al. Increased sensitivity to thermal pain following a single opiate dose is influenced by the COMT val(158)met polymorphism. PLoS One 2009, 4:e6016.
52. Stein D.J., Newman T.K., Savitz J., et al. Warriors versus worriers: the role of COMT gene variants. CNS Spectr 2006, 11:745-748.
53. Zubieta J.K., Heitzeg M.M., Smith Y.R., et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
54. Andersen S., Skorpen F. Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics 2009, 10:669-684.
55. Loggia M.L., Jensen K., Gollub R.L., et al. The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli. PLoS One 2011, 6:e27764.
56. Martinez-Jauand M., Sitges C., Rodriguez V., et al. Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene. Eur J Pain 2013, 17:16-27.
57. Debiec J., Conell-Price J., Evansmith J., et al. Mathematical modeling of the pain and progress of the first stage of nulliparous labor. Anesthesiology 2009, 111:1093-1110.
58. Reitman E., Conell-Price J., Evansmith J., et al. β2-adrenergic receptor genotype and other variables that contribute to labor pain and progress. Anesthesiology 2011, 114:927-939.
59. Algovik M., Kivinen K., Peterson H., et al. Genetic evidence of multiple loci in dystocia-difficult labour. BMC Med Genet 2010, 11:105.
60. Carroll C.L., Sala K.A., Zucker A.R., et al. β2-adrenergic receptor haplotype linked to intubation and mechanical ventilation in children with asthma. JAsthma 2012, 49:563-568.
61. Nagele P., Liggett S.B. Genetic variation, beta-blockers, and perioperative myocardial infarction. Anesthesiology 2011, 115:1316-1327.
62. Villar J., Papageorghiou A.T., Knight H.E., et al. The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynecol 2012, 206:119-123.
63. Landau R., Xie H.G., Dishy V., et al. β2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 2002, 187:1294-1298.
64. Ozkur M., Dogulu F., Ozkur A., et al. Association of the Gln27Glu polymorphism of the β2-adrenergic receptor with preterm labor. Int J Gynaecol Obstet 2002, 77:209-215.
65. Doh K., Sziller I., Vardhana S., et al. β2-adrenergic receptor gene polymorphisms and pregnancy outcome. JPerinat Med 2004, 32:413-417.
66. Landau R., Morales M.A., Antonarakis S.E., et al. Arg16 homozygosity of the β2-adrenergic receptor improves the outcome after β2-agonist tocolysis for preterm labor. Clin Pharmacol Ther 2005, 78:656-663.
67. Miller R.S., Smiley R.M., Daniel D., et al. β2-adrenoceptor genotype and progress in term and late preterm active labor. Am J Obstet Gynecol 2011, 205:137.e1-137.e7.
68. Terkawi A.S., Jackson W.M., Thiet M.P., et al. Oxytocin and catechol-O-methyltransferase receptor genotype predict the length of the first stage of labor. Am J Obstet Gynecol 2012, 207:184.e1-184.e8.
69. Esplin M.S., Merrell K., Goldenberg R., et al. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol 2011, 204:391.e1-391.e8.
70. Gracie S., Pennell C., Ekman-Ordeberg G., et al. An integrated systems biology approach to the study of preterm birth using "-omic" technology-a guideline for research. BMC Pregnancy Childbirth 2011, 11:71.
71. Landau R., Schwinn D. Genotyping without phenotyping: does it really matter?. Anesth Analg 2013, 116:8-10.
72. Landau R., Ortner C., Carvalho B. Challenges in interpreting joined allelic combinations of OPRM1 and COMT genes. Anesth Analg 2011, 113:432.
73. Lotsch J. Basic genetic statistics are necessary in studies of functional associations in anesthesiology. Anesthesiology 2007, 107:168-169.
74. Wong C.A. The promise of pharmacogenetics in labor analgesia... tantalizing, but not there yet. Int J Obstet Anesth 2012, 21:105-108.
75. Vuilleumier P.H., Stamer U.M., Landau R. Pharmacogenomic considerations in opioid analgesia. Pharmgenomics Pers Med 2012, 5:73-87.